Literature DB >> 10473226

Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae.

J Mitsuyama1.   

Abstract

The in-vitro bactericidal profiles of a number of quinolones against Streptococcus pneumoniae were investigated. Tosufloxacin was found to be the most bactericidal quinolone at the optimum bactericidal:MIC ratio (OBMR), followed by levofloxacin, ciprofloxacin and sparfloxacin, in order of potency. After exposure at the OBMR of each quinolone for 2 h, tosufloxacin showed a post-antibiotic effect (PAE) about 2.3-2.6 times longer than the other quinolones. Compounds with a 2,4-difluorophenyl group at the N-1 position in the quinolone nucleus had the greatest bactericidal activity and PAE. This activity exceeded that found with substitution of the quinolone nucleus at the C-7 position. Although the bactericidal activities of the quinolones correlated well with their PAEs, they were not always consistent with their MICs. These results suggest that bactericidal activity and PAE are governed by factors other than those which determine the MIC values, and a 2,4-difluorophenyl group at the N-1 position in the quinolone nucleus may play an important role in the expression of bactericidal activity and PAE against S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10473226     DOI: 10.1093/jac/44.2.201

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Identification of Anti-Persister Activity against Uropathogenic Escherichia coli from a Clinical Drug Library.

Authors:  Hongxia Niu; Peng Cui; Wanliang Shi; Shuo Zhang; Jie Feng; Yong Wang; David Sullivan; Wenhong Zhang; Bingdong Zhu; Ying Zhang
Journal:  Antibiotics (Basel)       Date:  2015-05-12

2.  A Clinical Drug Library Screen Identifies Tosufloxacin as Being Highly Active against Staphylococcus aureus Persisters.

Authors:  Hongxia Niu; Peng Cui; Rebecca Yee; Wanliang Shi; Shuo Zhang; Jie Feng; David Sullivan; Wenhong Zhang; Bingdong Zhu; Ying Zhang
Journal:  Antibiotics (Basel)       Date:  2015-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.